Hepcidin and Erythroferrone in the Anemia of Low-Risk Myelodysplastic Syndromes

被引：1
|
作者：
Oarbeascoa, Gillen [1 ]
Redondo, Sara [2 ]
Jose Moran-Jimenez, Maria [3 ]
Domingo, Amalia [1 ]
Munoz-Linares, Cristina [2 ]
Isabel Moreno-Carralero, Maria [4 ]
Maria Bellon, Jose [5 ]
del Campo Rincon, Juan Francisco [2 ]
Luis Diez-Martin, Jose [1 ,5 ,6 ]
Font, Patricia [1 ,5 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Hematol Dept, Madrid, Spain
[2] Hosp Univ Henares, Hematol Dept, Madrid, Spain
[3] Hosp 12 Octubre I 12, Inst Invest Sanitaria, Madrid, Spain
[4] Hosp 12 Octubre Imas12, Inst Invest Sanitaria, Madrid, Spain
[5] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[6] Univ Complutense Madrid, Dept Med, Madrid, Spain
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3085
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes
    Tehranchi, R
    MEDICAL ONCOLOGY, 2006, 23 (01) : 37 - 49
  • [32] Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features
    Fattizzo, Bruno
    Serpenti, Fabio
    Versino, Francesco
    Cassanello, Giulio
    Cro, Lilla M.
    Barbieri, Marzia
    Croci, Giorgio A.
    Revelli, Nicoletta
    Porta, Matteo G. Della
    Barcellini, Wilma
    BLOOD TRANSFUSION, 2023, 21 (05) : 452 - 460
  • [33] Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes
    R. Tehranchi
    Medical Oncology, 2006, 23 (1) : 37 - 49
  • [34] Erythroferrone and hepcidin levels in children with iron deficiency anemia
    Dulkadir, Ramazan
    Saltoglu, Gamze Turna
    Gunes, Ali
    BMC PEDIATRICS, 2024, 24 (01)
  • [35] Darbepoetin alfa for treating anemia in patients with low-risk myelodysplastic syndromes: Exploratory analysis of baseline predictors of response.
    Gabrilove, J.
    Paquette, R.
    Lyons, R.
    Mushtaq, C.
    Sekeres, M.
    Lam, H.
    Dreiling, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 356S - 356S
  • [36] Erythroferrone and hepcidin levels in children with iron deficiency anemia
    Ramazan Dulkadir
    Gamze Turna Saltoğlu
    Ali Güneş
    BMC Pediatrics, 24
  • [37] An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
    Teodorescu, Patric
    Pasca, Sergiu
    Choi, Inyoung
    Shams, Cynthia
    Dalton, W. Brian
    Gondek, Lukasz P.
    DeZern, Amy E.
    Ghiaur, Gabriel
    HAEMATOLOGICA, 2024, 109 (01) : 337 - 342
  • [38] Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes
    Golshayan, Ali-Reza
    Jin, Tao
    Maciejewski, Jaroslaw
    Fu, Alex Z.
    Bershadsky, Boris
    Kattan, Michael W.
    Kalaycio, Matt E.
    Sekeres, Mikkael A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (02) : 125 - 132
  • [39] A decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
    Sekeres, MA
    Fu, AZ
    Maciejewski, JP
    Golshayan, AR
    Kalaycio, M
    Kattan, MW
    BLOOD, 2005, 106 (11) : 711A - 711A
  • [40] The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances
    Randall, Michael P.
    DeZern, Amy E.
    CANCER JOURNAL, 2023, 29 (03) : 152 - 159
12345